Alerts will be sent to your verified email
Verify Email
HEMORGANIC
|
Hemo Organic
|
MPS Pharmaa
|
Zyden Gentec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-343.55 % | -41.86 % | -24.76 % |
|
5yr average Equity Multiplier
|
4.83 | 3.24 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.0 | 0.21 |
|
5yr Avg Net Profit Margin
|
-766.15 % | -5434.45 % | -137.59 % |
|
Price to Book
|
0.0 | 4.63 | n/a |
|
P/E
|
23.92 | 0.0 | n/a |
|
5yr Avg Cash Conversion Cycle
|
-1382.2 Days | 0.0 | 785.76 Days |
|
Inventory Days
|
364.55 Days | 1258.79 Days | 134.34 Days |
|
Days Receivable
|
1156.1 Days | 0.0 | 803.05 Days |
|
Days Payable
|
2873.52 Days | 414.72 Days | 421.99 Days |
|
5yr Average Interest Coverage Ratio
|
-254.04 | -816.29 | -2.08 |
|
5yr Avg ROCE
|
52.28 % | -41.48 % | -6.92 % |
|
5yr Avg Operating Profit Margin
|
-746.74 % | -3500.38 % | -95.87 % |
|
5 yr average Debt to Equity
|
1.23 | 1.97 | 0.68 |
|
5yr CAGR Net Profit
|
67.03 % | -6.64 % | -1.66 % |
|
5yr Average Return on Assets
|
-38.14 % | -13.25 % | -15.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
16.85 % | 35.89 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 16.04 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Hemo Organic
|
MPS Pharmaa
|
Zyden Gentec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|